Clinical Trials Browser

Phase 2 × OTHER × CTL019 chimeric antigen receptor × Clear all

NCT04778579 2024-06-26

CART19-BE-02

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02030834 2023-06-22

Phase IIa Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRz and 4-Signaling Domains in Patients With Chemotherapy Relapsed or Refractory CD19+ Lymphomas

Phase 2 Completed

63 enrolled 10 charts

Lymphoma, Non-Hodgkin